AmerisourceBergen Corporation (ABC)
(Delayed Data from NYSE)
$79.14 USD
+2.08 (2.70%)
Updated May 3, 2019 04:01 PM ET
After-Market: $79.11 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.14 USD
+2.08 (2.70%)
Updated May 3, 2019 04:01 PM ET
After-Market: $79.11 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
AmerisourceBergen (ABC) Down 1.8% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
AmerisourceBergen (ABC) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen's PharMEDium Slows Down, Competition Rife
by Zacks Equity Research
AmerisourceBergen Corporation (ABC) is facing immediate integration risks from its acquisition of PharMEDium. Also, competition in the generic space raise concern.
AmerisourceBergen (ABC) Q3 Earnings Beat, Sales Miss
by Zacks Equity Research
AmerisourceBergen (ABC) beat the Zacks Consensus Estimate of $1.37 per share with the company reported adjusted earnings of $1.43 per share.
AmerisourceBergen's PharMEDium Slows Down, Competition Rife
by Zacks Equity Research
On Jul 10, we issued an updated research report on Chesterbrook, PA-based AmerisourceBergen Corporation (ABC).
Is AmerisourceBergen (ABC) Stock a Good Value Pick Now?
by Zacks Equity Research
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
AmerisourceBergen (ABC) Up 7.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmerisourceBergen (ABC) Q2 Earnings Beat, Sales Miss
by Zacks Equity Research
AmerisourceBergen topped earnings in the second quarter. Our consensus called for earnings of $1.71 per share, and the company reported adjusted earnings of $1.77 per share.
AmerisourceBergen (ABC) Up 4.1% Since Earnings Report: Can It Continue?
by Zacks Equity Research
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is AmerisourceBergen (ABC) a Good Choice for Value Investors?
by Zacks Equity Research
AmerisourceBergen (ABC) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Acadia Healthcare (ACHC) Tops Q4 Earnings, Gives 2017 View
by Zacks Equity Research
Acadia Healthcare Company Inc. (ACHC) reported fourth-quarter 2016 adjusted earnings of 59 cents per share, which surpassed the Zacks Consensus Estimate by 4 cents.
Zacks.com featured highlights: American Axle & Manufacturing Holdings, AmerisourceBergen, Basic Energy Services, Diplomat Pharmacy and California Resources
by Zacks Equity Research
Zacks.com featured highlights: American Axle & Manufacturing Holdings, AmerisourceBergen, Basic Energy Services, Diplomat Pharmacy and California Resources
Moving Average Crossover Alert: AmerisourceBergen (ABC)
by Zacks Equity Research
AmerisourceBergen Corporation (ABC) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
AmerisourceBergen (ABC) Q1 Earnings Beat, Sales Miss
by Zacks Equity Research
AmerisourceBergen topped earnings in the reported quarter.
Medical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC
by Zacks Equity Research
Let's take a look at the major Medical Product stocks slated to release their earnings results on tomorrow.
AmerisourceBergen (ABC) Q1 Earnings: Will It Disappoint?
by Zacks Equity Research
AmerisourceBergen Corp. (ABC) is set to report first-quarter fiscal 2017 results on Jan 31, before the opening bell.
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?
by Zacks Equity Research
McKesson Corporation (MCK), one of the largest healthcare services providers, is scheduled to report third-quarter fiscal 2017 results on Jan 25.
McKesson (MCK) to Pay $150 Million to Department of Justice
by Zacks Equity Research
McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.
Should Value Investors Consider AmerisourceBergen Stock?
by Zacks Equity Research
Value Investors might consider AmerisourceBergen (ABC) as a great pick on the back of its key value statistics.
Big Data/Short Week Continues
by Mark Vickery
We're 2 days ahead of the big June Jobs Report. Until that time, we have plenty to chew on.